By Steven Trader ( March 10, 2016, 4:02 PM EST) -- A California state appeals court ruled Wednesday that brand-name drug maker Novartis could be held liable for negligent misrepresentation and failure to warn of the alleged dangers of a generic version of its drug, even though Novartis stopped making the name-brand drug years before the damage occurred....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.